Biblio
Export 34 results:
Author [ Title] Type Year Filters: Author is Scheltens, Philip [Clear All Filters]
“Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
, ,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”, J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
, “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
, “Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1827-1839, 2018.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.”, J Alzheimers Dis, vol. 49, no. 3, pp. 617-31, 2016.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?”, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
,